Telemetry Investments’s Insmed INSM Stock Holding History

Telemetry Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,000	Closed	-$228K	–	166
2021 Q2	$228K	Buy	+8,000	New	+$237K	0.31%	93

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Telemetry Investments's INSM Position: Q3 2021 in Review

Telemetry Investments sold out of Insmed (INSM) in Q3 2021, closing a stake of 8,000 shares — an estimated $228K sold.

Telemetry Investments first reported a position in INSM in Q2 2021 and held it in 1 quarter. The position peaked at $228K in Q2 2021. 193 funds tracked by Wall St. Rank hold INSM as of Q3 2021.

Telemetry Investments reported no remaining Insmed position as of Q3 2021 after selling out during the quarter.
Telemetry Investments sold 8,000 Insmed shares in Q3 2021, an estimated $228K.
Telemetry Investments first reported a position in Insmed in Q2 2021 and held it in 1 quarter.
Telemetry Investments's Insmed position peaked at $228K in Q2 2021.
193 funds tracked by Wall St. Rank held Insmed as of Q3 2021.

Based on Telemetry Investments's 13F filing for Q3 2021, filed 15 Nov 2021.